Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Access Pharmaceuticals Announces Publication Of Thiarabine Combination Data
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), announced that new Thiarabine preclinical efficacy data will shortly be published demonstrating that thiarabine combined with clofarabine provides much greater antitumor activity than achieved by either agent alone. In one colorectal cancer model, 66% of mice were cured of their tumors. The publication which will appear in the journal "Cancer Chemotherapy and Pharmacology," was based on work conducted by Access" collaborators at the Southern Research Institute. The paper is entitled "Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine" (thiarabine).
generic viagra online
Jellyfish Shed Fluorescent Light On How The Brain Works
Scientists at the University of Leicester are developing new ways of studying how brain cells work -thanks to jellyfish!
News of the day
New Online Re Launches For Patients With Chronic Myeloid Leukemia
Many people living with cancer are researching their illnesses online. In fact, research has shown that patients who use the Internet consider it a more useful of information as compared with other media. Further, patients" Internet use can encourage active communication with their physicians.
Endocrinology

Nonin Medical Announces FDA Clearance For Its Next-Generation Regional Oximetry System

Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, announced FDA clearance for its Model 7600 Regional Oximetry System. Introduced in June 2009 at the European Society of Anaesthesiology (ESA) conference in Milan, Italy, the innovative Model 7600 offers real-time monitoring of cerebral oxygenation for patients at risk of ischemia. Utilizing next-generation near-infrared spectroscopy (NIRS) -- Nonin"s proprietary EQUANOX(TM) regional oximetry (rSO2) technology -- the Model 7600 measures oxygen saturation in the cerebral cortex. The innovative sensor design effectively removes surface tissue effects that can influence measurement accuracy -- isolating measurements of the cerebral cortex and providing rSO2 values. The Model 7600 offers industry-leading signal processing to enhance efficiency and an intuitive user interface with Bluetooth(R) wireless connectivity to streamline file access and storage. With over 20 years of signal processing and NIRS sensor design expertise, Nonin"s innovative technologies enable clinicians to accurately monitor a patient"s true condition in the most challenging environments. About Nonin Medical Inc Minneapolis-based Nonin Medical, Inc. is a privately owned company specializing in the design and manufacturing of noninvasive physiological monitoring solutions. Nonin distributes its products to health professionals in more than 125 countries and has over 100 OEM partners worldwide. Nonin"s industry-leading capabilities in signal processing and sensor design, plus its on-going integration of features not available in competitive products, are the foundation of its leadership in innovation. Nonin Medical, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009